dwtechm3bg

Gbasara anyị

Gbasara anyị

Nkọwapụta Ụlọ ọrụ

Great Bay Bio (GBB), nke hiwere isi na Hong Kong, hiwere na 2019 nwere ukwu ukwu na Greater Bay Area.N'ịgbaso ọhụụ ụlọ ọrụ nke "Global Bioprocessing mere dị mfe ma dị irè", GBB na-agba mbọ itinye AI na teknụzụ ndị ọzọ na-emepe emepe iji kwalite ihe ọhụrụ bioprocessing, si otú a dozie isi ihe mgbu, dị ka ogologo oge, ọnụ ahịa dị elu na ọnụ ọgụgụ dị ala. na mmepe ọgwụ GBB na-ewere ịkwalite ndụ mmadụ, ahụike na uru dị ka ebumnuche ya ogologo oge.

Otu isi nke GBB nwere talent zuru ụwa ọnụ nwere nka na ọgwụ, ụlọ ahịa ọgwụ, bayoloji sịntetik na AI.Na 3000 m2R&D center na CMC ikpo okwu, GBB akwalitela ọtụtụ ọgwụ nje n'ime ogbo NDA, gụnyere ọgwụ ọhụrụ klaasị 1 nke mba.N'ime afọ atọ kemgbe nguzobe ya, GBB etinyela akwụkwọ maka ihe karịrị patent 30 maka ngwọta bioprocesses AI nyere ike.Azụpụtara nyiwe AI ndị a rụpụtara nke ọma, na-enyere GBB aka ịmalite imekọ ihe ọnụ ogologo oge ya na ọtụtụ ụlọ ọrụ na-eduga n'ụlọ na nke mba ofesi.

GBB enwetala utu aha nke National "High-Tech Enterprise" ugboro abụọ n'usoro site na National High-Tech Enterprise Certification Management Leading Group Office, "Ndepụta Epupụta Ọtụtụ ụlọ ọrụ bara uru maka itinye ego na China maka afọ 2020" site na Zero2IPO Group, Ụlọ ọrụ 50 kachasị ọhụrụ na-emepụta ihe na-emepụta ihe na-emepụta ihe na Guangdong-Hong Kong-Macao Greater Bay Area Award 2020 site na ZDVC RESEARCH na KPMG China, "Top 15 na 2021 Merck Greater Bay Area Innovation Bootcamp" na "Spring class of Microsoft accelerator inccelerator in accelerator plan. 2022".

2021
2022
2021

Eserese Strategic Alliance na Cheerland Life Science.

Eserese Strategic Alliance na ChemPartner.

GBB sonyeere mmemme mmalite nke NVIDIA nke ọma wee nweta ihe nrite pụrụ iche nke ihe ngosi ikpeazụ nke mmalite NVIDIA.

Ezuchala usoro nzụkọ ego ruru ihe fọrọ nke nta ka ọ bụrụ USD 10M.

Enyere Gen.T Social Mmetụta na Onye Ndú nke Echi 2021.

Banye Top 15 nke 2021 Merck Greater Bay Mpaghara Innovation Bootcamp.

Batara Hong Kong Science Park.

Ngwakọta Strategic dabara na Chime Biologics.

Ewepụtara AI-enyere aka Cell Line Stability Prediction Platform, AlfaStaX®.

Ewepụtara AI-enyere Cell Culture Media Development Platform aka, AlfaMedX®.

Emechara USD 3.8M Ntinye ego ndetu na-agbanwe agbanwe nke Alibaba Hong Kong Entrepreneurs Fund na-edu.

2022

Ewepụtara saịtị-Specific Integration Cell Line Development Platform, AlfaCell®.

Nweta ego ijeri USD 15M tupu usoro B nke Tiger Jade Capital na-edu.

Edepụtara na 2022 Spring Semester nke Mmemme Acceleration Microsoft.

3000m

Ụlọ nyocha R&D

30+

Patent ndị metụtara bayoloji

30+

Ọrụ IND

20+

Patent ndị metụtara Al

100+

Ndị ahịa GBB